No abstract available
MeSH terms
-
Angiotensin-Converting Enzyme Inhibitors / economics*
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Cost of Illness
-
Cost-Benefit Analysis*
-
Developed Countries
-
Economics, Pharmaceutical
-
Heart Failure / drug therapy
-
Heart Failure / economics*
-
Humans
-
Quality-Adjusted Life Years
-
Retrospective Studies
-
Treatment Outcome
Substances
-
Angiotensin-Converting Enzyme Inhibitors